                               SEQUENCE LISTING

<110> THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONAL CHARTERED
      NOT-FOR-PROFIT CORPORATION
 
<120> ANGIOTENSIN II ALONE OR IN COMBINATION FOR THE TREATMENT OF 
      HYPOTENSION

<130> 123585-375383

<140>
<141>

<150> 61/955,706
<151> 2014-03-19

<150> 61/917,576
<151> 2013-12-18

<160> 8     

<170> PatentIn version 3.5

<210> 1
<211> 8
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: Angiotensin II
      peptide

<400> 1
Asp Arg Val Tyr Ile His Pro Phe 
1               5               


<210> 2
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Asp Arg Val Tyr Val His Pro Phe 
1               5               


<210> 3
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Asn Arg Val Phe Ile His Pro Phe 
1               5               


<210> 4
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Val Tyr Ile His Pro Phe 
1               5       


<210> 5
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Asn Arg Val Tyr Tyr Val His Pro Phe 
1               5                   


<210> 6
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Asn Arg Val Tyr Ile His Pro Ile 
1               5               


<210> 7
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Asn Arg Val Tyr Ile His Pro Ala 
1               5               


<210> 8
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (4)..(4)
<223> diiodo-Tyr

<400> 8
Asn Arg Val Tyr Ile His Pro Phe 
1               5               


